UBS starts Cerner (NASDAQ:CERN) at a Buy-equivalent rating and $84 target.
Analyst Kevin Caliendo sees a “clear pathway” to margin upside and stable long-term growth.
The analyst also praises CERN’s “sizeable balance sheet firepower” and expects a more aggressive focus on capital allocation.
Cerner shares are up 1.3% pre-market to $71.60.
CERN has a Bullish average SA Author’s rating.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.